American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

GH Lyman, M Carrier, C Ay, M Di Nisio… - Blood …, 2021 - ashpublications.org
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

B Bikdeli, MV Madhavan, D Jimenez, T Chuich… - Journal of the American …, 2020 - jacc.org
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology

MB Streiff, B Holmstrom, D Angelini, A Ashrani… - Journal of the National …, 2021 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

GD Barnes, A Burnett, A Allen, M Blumenstein… - Journal of thrombosis …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases,
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …

Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report

LK Moores, T Tritschler, S Brosnahan, M Carrier… - Chest, 2020 - Elsevier
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …

[HTML][HTML] Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis

S Nopp, F Moik, B Jilma, I Pabinger, C Ay - Research and practice in …, 2020 - Elsevier
Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …

Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update

NS Key, AA Khorana, NM Kuderer, K Bohlke… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide updated recommendations about prophylaxis and treatment of
venous thromboembolism (VTE) in patients with cancer. METHODS PubMed and the …

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

HJ Schünemann, M Cushman, AE Burnett… - Blood …, 2018 - ashpublications.org
In October 2022, these guidelines were reviewed by an expert work group convened by
ASH. Review included limited searches for new evidence and discussion of the search …

Diretriz brasileira de insuficiência cardíaca crônica e aguda

LEP Rohde, MW Montera, EA Bocchi… - Arq. bras …, 2018 - pesquisa.bvsalud.org
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …

A test in context: D-dimer

JI Weitz, JC Fredenburgh, JW Eikelboom - Journal of the American College …, 2017 - jacc.org
D-dimer is a soluble fibrin degradation product that results from ordered breakdown of
thrombi by the fibrinolytic system. Numerous studies have shown that D-dimer serves as a …